Resonant Venture Partners

Managing partners Michael Godwin and Jason Townsend share investment decision authority and take board seats together on portfolio companies. Before founding Resonant in 2010, Godwin and Townsend had built and sold a web-based business, giving them direct operational context for the early-stage technical founders they back. The firm does not publish a formal investment committee list beyond the two managing partners, a structure typical for a partnership of its size.

Resonant relies on an explicit University of Michigan bias — founder referrals through alumni networks, university technology transfer events, and campus-based technical talent pipelines represent a substantial share of its top-of-funnel activity. The firm also cultivates relationships with Ohio and Michigan-based accelerators and regional economic development organizations. Ann Arbor's density of engineering and health informatics graduates creates a recurring on-ramp to companies before they seek coastal capital.

Resonant leads or co-leads pre-seed, seed, and Series A rounds, entering at the point of first institutional capital. The firm's preference is to price the round and secure a board seat rather than participate passively. It has publicly stated a willingness to invest in pre-revenue companies when the technical team and problem set align with its enterprise software or digital health focus.

The firm has publicly concentrated on enterprise software, AI/ML, and digital health. While not formally blacklisting other sectors, Resonant has historically avoided direct retail consumer internet, hardware-heavy deep tech, and capital-intensive life sciences requiring multi-year FDA pathways — areas where its check size and partnership bandwidth offer less structural advantage.

Resonant is an independent private firm, not a university-affiliated venture fund. However, the firm's Ann Arbor headquarters is less than two miles from the University of Michigan campus, and its co-founders maintain deep ties to faculty, alumni, and research groups there. This proximity functions as the firm's primary network anchor for deal origination rather than a formal investment mandate linked to university endowment assets.

The firm has historically reserved capital for pro-rata follow-on in the highest-performing portfolio companies. Given the thin institutional venture layer in the Midwest, Resonant's ability to bridge companies from seed to a credible Series B-ready state has been a core part of its pitch to founders considering whether to remain headquartered in Michigan rather than relocating to raise growth-stage funding elsewhere.